The accumulation of a glucosphingolipid (GSL) in individuals lacking an adequate level of hydrolase activity could be minimized by chemotherapeutic measures that slow the formation of the GSL and stimulate the defective hydrolase. By achieving a balance in the rates of formation and breakdown, one should be able to alleviate the symptoms of excess storage and achieve a satisfactory accommodation. While several drugs seem to be specifically suitable for this purpose, only one of these has been approved for human use. However, less effective drugs and over-the-counter substances are available for human use and may prove satisfactory for a few years until better ones are made available. The proposed materials and the evidence behind the recomm...
Glycogen storage disease (GSD) is a rare genetic disorder that disrupts proper metabolic function wi...
Glycosphingolipids (GSLs), the main topic of this review, are a subclass of sphingolipids. With thei...
Inherited defects in the degradation of glycosphingolipids (GSLs) cause a group of severe diseases k...
The hypothesis is offered predicting that Caucher patients could be treated with a drug that slows t...
Glycosphingolipid (GSL) lysosomal storage disorders are a small but challenging group of human disea...
The glycosphingolipidoses are a family of storage diseases that arise due to incomplete catabolism o...
Substrate reduction therapy is a novel approach to treating glycosphingolipid (GSL) lysosomal storag...
The glycolipid lysosomal storage diseases are a collection of rare, inherited disorders of metabolis...
The glycosphingolipid (GSL) lysosomal storage diseases are caused by mutations in the genes encoding...
ABSTRACT. The glycosphingolipid (GSL) lysosomal storage diseases result from mutations in the genes ...
BACKGROUND: Current treatment for Gaucher's disease involves administration of intravenous glucocere...
Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to...
Glycosphingolipid (GSL) metabolism is a complex process involving proteins and enzymes at distinct l...
A model of the human genetic disorder, Gaucher disease, can be rapidly generated in mice by the inje...
The ceramide analog, -threo-1-phenyl-2-decanoylamino-3-morpholino-1-morpholino-1-propanol, inhibits ...
Glycogen storage disease (GSD) is a rare genetic disorder that disrupts proper metabolic function wi...
Glycosphingolipids (GSLs), the main topic of this review, are a subclass of sphingolipids. With thei...
Inherited defects in the degradation of glycosphingolipids (GSLs) cause a group of severe diseases k...
The hypothesis is offered predicting that Caucher patients could be treated with a drug that slows t...
Glycosphingolipid (GSL) lysosomal storage disorders are a small but challenging group of human disea...
The glycosphingolipidoses are a family of storage diseases that arise due to incomplete catabolism o...
Substrate reduction therapy is a novel approach to treating glycosphingolipid (GSL) lysosomal storag...
The glycolipid lysosomal storage diseases are a collection of rare, inherited disorders of metabolis...
The glycosphingolipid (GSL) lysosomal storage diseases are caused by mutations in the genes encoding...
ABSTRACT. The glycosphingolipid (GSL) lysosomal storage diseases result from mutations in the genes ...
BACKGROUND: Current treatment for Gaucher's disease involves administration of intravenous glucocere...
Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to...
Glycosphingolipid (GSL) metabolism is a complex process involving proteins and enzymes at distinct l...
A model of the human genetic disorder, Gaucher disease, can be rapidly generated in mice by the inje...
The ceramide analog, -threo-1-phenyl-2-decanoylamino-3-morpholino-1-morpholino-1-propanol, inhibits ...
Glycogen storage disease (GSD) is a rare genetic disorder that disrupts proper metabolic function wi...
Glycosphingolipids (GSLs), the main topic of this review, are a subclass of sphingolipids. With thei...
Inherited defects in the degradation of glycosphingolipids (GSLs) cause a group of severe diseases k...